Open AccessAbstract 391: Lrg1 blockade modulates the tumor immune microenvironment and improves the efficacy of cancer therapeutics
Author(s) -
Carlotta Camilli,
Camilla Pilotti,
Marie O’Connor,
David Kallenberg,
Markella Alatsatianos,
Hannah Watson,
Julia Ohme,
Athina Dritsoula,
Ann Ager,
Stephen E. Moss,
John Greenwood
Publication year - 2020
Publication title -
cancer research
Language(s) - English
Resource type - Conference proceedings
SCImago Journal Rank - 1.055
H-Index - 84
eISSN - 1538-7445
pISSN - 0008-5472
DOI - 10.1158/1538-7445.am2020-391
Subject(s) - blockade , tumor microenvironment , extravasation , medicine , cancer research , immune checkpoint , cd8 , immune system , t cell , blocking antibody , melanoma , cytotoxic t cell , immunology , inflammation , immunotherapy , antigen , chemistry , receptor , in vitro , biochemistry